Frédéric Kesteloot

451 total citations
6 papers, 353 citations indexed

About

Frédéric Kesteloot is a scholar working on Molecular Biology, Immunology and Allergy and Cancer Research. According to data from OpenAlex, Frédéric Kesteloot has authored 6 papers receiving a total of 353 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Immunology and Allergy and 3 papers in Cancer Research. Recurrent topics in Frédéric Kesteloot's work include Angiogenesis and VEGF in Cancer (3 papers), Cell Adhesion Molecules Research (3 papers) and Connective tissue disorders research (2 papers). Frédéric Kesteloot is often cited by papers focused on Angiogenesis and VEGF in Cancer (3 papers), Cell Adhesion Molecules Research (3 papers) and Connective tissue disorders research (2 papers). Frédéric Kesteloot collaborates with scholars based in Belgium, Netherlands and France. Frédéric Kesteloot's co-authors include Alain Colige, Betty Nusgens, Johanne Dubail, Charles M. Lapière, Carine Le Goff, David E. Birk, Kimerly Powell, Robert Somerville, Suneel Apte and Isabel Vandenberghe and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Experimental Medicine and The Journal of Cell Biology.

In The Last Decade

Frédéric Kesteloot

6 papers receiving 348 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Frédéric Kesteloot Belgium 5 170 109 73 73 57 6 353
Bon-Hun Koo South Korea 9 167 1.0× 146 1.3× 70 1.0× 92 1.3× 49 0.9× 9 399
Yuri Miyazawa Japan 10 223 1.3× 69 0.6× 160 2.2× 50 0.7× 24 0.4× 33 464
Helga Moch Germany 7 209 1.2× 76 0.7× 33 0.5× 66 0.9× 18 0.3× 7 332
Simon J. Foulcer United States 5 167 1.0× 129 1.2× 78 1.1× 72 1.0× 43 0.8× 7 389
Tiina Hurskainen Finland 11 143 0.8× 126 1.2× 80 1.1× 133 1.8× 46 0.8× 14 557
Ida Villanova Italy 10 207 1.2× 136 1.2× 194 2.7× 81 1.1× 20 0.4× 18 429
Albane A. Bizet Canada 6 279 1.6× 55 0.5× 114 1.6× 61 0.8× 56 1.0× 8 427
Yoshifumi Ninomiya Japan 7 173 1.0× 62 0.6× 32 0.4× 204 2.8× 73 1.3× 7 416
Florence Brellier Switzerland 16 291 1.7× 115 1.1× 109 1.5× 192 2.6× 67 1.2× 21 545
Goedele Wallays Belgium 8 137 0.8× 145 1.3× 69 0.9× 51 0.7× 17 0.3× 10 399

Countries citing papers authored by Frédéric Kesteloot

Since Specialization
Citations

This map shows the geographic impact of Frédéric Kesteloot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frédéric Kesteloot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frédéric Kesteloot more than expected).

Fields of papers citing papers by Frédéric Kesteloot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frédéric Kesteloot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frédéric Kesteloot. The network helps show where Frédéric Kesteloot may publish in the future.

Co-authorship network of co-authors of Frédéric Kesteloot

This figure shows the co-authorship network connecting the top 25 collaborators of Frédéric Kesteloot. A scholar is included among the top collaborators of Frédéric Kesteloot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frédéric Kesteloot. Frédéric Kesteloot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Dubail, Johanne, Frédéric Kesteloot, Claude Deroanne, et al.. (2010). ADAMTS-2 functions as anti-angiogenic and anti-tumoral molecule independently of its catalytic activity. Cellular and Molecular Life Sciences. 67(24). 4213–4232. 62 indexed citations
2.
Colige, Alain, Christophe Deroanne, Johanne Dubail, et al.. (2008). Newly identified biologically active and proteolysis-resistant VEGF-A isoform VEGF111 is induced by genotoxic agents. The Journal of Experimental Medicine. 205(1). i2–i2. 3 indexed citations
3.
Kesteloot, Frédéric, Alexis Desmoulière, Isabelle Leclercq, et al.. (2007). ADAM metallopeptidase with thrombospondin type 1 motif 2 inactivation reduces the extent and stability of carbon tetrachloride–induced hepatic fibrosis in mice. Hepatology. 46(5). 1620–1631. 47 indexed citations
4.
Colige, Alain, Christophe Deroanne, Johanne Dubail, et al.. (2007). Newly identified biologically active and proteolysis-resistant VEGF-A isoform VEGF111 is induced by genotoxic agents. The Journal of Cell Biology. 179(6). 1261–1273. 72 indexed citations
5.
Goff, Carine Le, Robert Somerville, Frédéric Kesteloot, et al.. (2006). Regulation of procollagen amino-propeptide processing during mouse embryogenesis by specialization of homologous ADAMTS proteases: insights on collagen biosynthesis and dermatosparaxis. Development. 133(8). 1587–1596. 80 indexed citations
6.
Colige, Alain, Florence Ruggiero, Isabel Vandenberghe, et al.. (2005). Domains and Maturation Processes That Regulate the Activity of ADAMTS-2, a Metalloproteinase Cleaving the Aminopropeptide of Fibrillar Procollagens Types I–III and V. Journal of Biological Chemistry. 280(41). 34397–34408. 89 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026